Objective: The therapeutic strategy in non-small-cell lung cancer (NSCLC) requires exact
staging of tumour invasion (T) as well as differentiation between ipsi-and contralateral lymph …

Abstract Objective: F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) has
become an important staging tool for patients with lung cancer, and determination of the …

Background To better describe clinical T descriptors using solid tumor size (the maximum
dimension of the solid component of the tumor) on high-resolution computed tomography …

Therapeutic decisions in non–small cell lung cancer (NSCLC) patients depend on the tumor
stage. PET/CT with 18F-FDG is widely accepted as the diagnostic standard of care. The …

Accurate staging is essential to offer the patient the most effective available treatment and
the best estimate of prognosis. In non-small cell lung cancer (NSCLC), surgical resection …

This communication presents an update on the current role of positron emission tomography-
computed tomography (PET-CT) in the various clinical decision-making steps in lung …

Accurately staging patients with lung cancer is important in determining treatment options
and prognoses. Staging allows the distinction of patients who are candidates for surgical …

Objectives Lung adenocarcinoma frequently manifests as subsolid nodules, and the solid
portion and ground-glass-opacity (GGO) portion on CT have different prognostic …

Simple Summary Prognostic considerations for non-predominant histologic patterns are
necessary because most lung adenocarcinomas have a mixed histologic pattern. We aimed …

Positron emission tomography (PET) is more accurate than computed tomography (CT) in
the staging of non-small cell lung cancer (NSCLC). We analyzed the prognostic value of …